Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Forget the Doom-and-Gloom, Now Is a Time to Be Bullish A little girl named Carol Anne became famous for saying "They're h-eee-rrr-e" in the 1982 movie "Poltergeist."
    She was talking about the "TV people."
    Well, we have our equivalent digital denizens, and they're also returning in force lately. Except ours are largely from the investment shadows, awaiting the next opportunity to brandish heavy fear tactics to convince you the energy market is about to collapse... again. (These guys have correctly predicted eight of the last three recessions.)
    At issue this time is the latest financial obstacle the market must overcome: the sequestration scheduled to hit a week from today. The draconian cuts will occur automatically, although it will also take at least a month for them to have any impact. Of course, the markets are not going to wait that long. For the past two days, the first wave of nail biting started.
    But I urge you to ignore those talking heads - and as Congress gets back to "business."
    Here's why. Read More...
  • Our Economic Recovery has been Hijacked Money Morning Chief Investment Strategist Keith Fitz-Gerald joined CNBC Asia's "Squawk Box" program to discuss U.S. President Barack Obama's new jobs proposal. President Obama is in a tough spot, trying to get approval for new tax increases to pay for a $447 billion jobs package -- and Fitz-Gerald said it's unlikely he'll be able to appease Congress enough to get the plan approved. Fitz-Gerald talked to CNBC about how many politicians' personal agendas have impeded U.S. economic recovery, and what should be done to improve economic progress.

    Loading the player ... jwplayer("container").setup({ autostart: true, controlbar:... Read More...